---
title: "Vazyme's subsidiary products have obtained medical device registration certificates"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/258668761.md"
description: "Vazyme's wholly-owned subsidiary, Nanjing Vazyme Medical Technology Co., Ltd., recently obtained multiple medical device registration certificates, involving a series of diagnostic reagent products for the nervous system. The company relies on its antibody technology platform to continuously enrich its AD blood test series products and innovatively develop precise detection products for Parkinson's disease and brain injuries, aiming to meet clinical needs in the field of neurological diseases and enhance the diagnosis and treatment service level for brain health and cognitive disorders"
datetime: "2025-09-24T09:43:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258668761.md)
  - [en](https://longbridge.com/en/news/258668761.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258668761.md)
---

# Vazyme's subsidiary products have obtained medical device registration certificates

According to the Zhitong Finance APP, Vazyme (688105.SH) announced that its wholly-owned subsidiary, Nanjing Vazyme Medical Technology Co., Ltd., has recently obtained multiple "Medical Device Registration Certificates" for several series of diagnostic reagent products for the nervous system in China.

Relying on its own antibody technology platform, the company continues to enrich its AD blood test series products based on global authoritative guidelines, while focusing on key areas in major diseases of the central nervous system. It innovatively develops precise detection and diagnostic products for Parkinson's disease, brain injuries, and other conditions, aiming to address unmet clinical needs in the field of neurological diseases. The company is committed to continuously enhancing the product strength and influence of its chemiluminescence platform, contributing to the improvement of brain health and cognitive disorder diagnosis and treatment services in China, and actively practicing the "Healthy China Strategy." The acquisition of this product registration certificate only represents that the company's related products have obtained market access qualifications in the domestic market

### Related Stocks

- [688105.CN](https://longbridge.com/en/quote/688105.CN.md)

## Related News & Research

- [Adnoc CEO: The US is top investment priority for the UAE](https://longbridge.com/en/news/287066990.md)
- [Oil little changed as traders await breakthrough in US.-Iran negotiations](https://longbridge.com/en/news/286925961.md)
- [05:20 ETThrough the America's Most Artistic Kid Competition, Colossal Raises $1.6 Million While Celebrating the Next Gen of Creative Visionaries](https://longbridge.com/en/news/287037755.md)
- [08:03 ETNCCN reafirma su compromiso con los recursos para el manejo del malestar relacionado con el cáncer](https://longbridge.com/en/news/287060831.md)
- [Ipsen Reports First Head-to-Head Data Showing Dysport Provides Longer Symptom Control Than Botox](https://longbridge.com/en/news/287036494.md)